People who receive Pfxxxr’s respiratory syncytial virus vxxxxxe should be monitored for Guillain-Barré syndrome, according to the authors of a Pfxxxr-funded study published this week in the New England Journal of Medicine. https://childrenshealthdefense.org/defender/pfizer-rsv-vaccine-guillain-barre-syndrome-older-adults/